Cargando…
Nanoparticle-Mediated Cytoplasmic Delivery of Messenger RNA Vaccines: Challenges and Future Perspectives
The COVID-19 pandemic has left scientists and clinicians no choice but a race to find solutions to save lives while controlling the rapid spreading. Messenger RNA (mRNA)-based vaccines have become the front-runners because of their safety profiles, precise and reproducible immune response with more...
Autores principales: | Wu, Zimei, Li, Tonglei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928182/ https://www.ncbi.nlm.nih.gov/pubmed/33660201 http://dx.doi.org/10.1007/s11095-021-03015-x |
Ejemplares similares
-
Chitosan-based nanoparticles in Alzheimer’s disease: messenger or message?
por: Manek, Eniko, et al.
Publicado: (2021) -
Editorial of Special Issue “Cytoplasmic Delivery of Bioactives”
por: Wu, Zimei
Publicado: (2022) -
Allergy evaluation of messenger RNA vaccine reactions is crucial, with a specific role for polyethylene glycol testing
por: Shrestha, Pragya, et al.
Publicado: (2022) -
Pregnancy should be a condition eligible for additional doses of COVID-19 messenger RNA vaccines
por: Faust, Jeremy Samuel, et al.
Publicado: (2023) -
Perspective: Challenges and Future Directions in Clinical Research with Nuts and Berries
por: Zuelch, Michelle L., et al.
Publicado: (2023)